Format
Sort by
Items per page

Send to

Choose Destination

Best matches for mometasone/PD OR formoterol/PD:

Search results

Items: 1 to 20 of 201

1.

Does intranasal steroid spray technique affect side effects and compliance? Results of a patient survey.

Ganesh V, Banigo A, McMurran AEL, Shakeel M, Ram B.

J Laryngol Otol. 2017 Nov;131(11):991-996. doi: 10.1017/S0022215117002080. Epub 2017 Oct 20.

PMID:
29050548
2.

Neuroendocrine Modulation of IL-27 in Macrophages.

Roewe J, Higer M, Riehl DR, Gericke A, Radsak MP, Bosmann M.

J Immunol. 2017 Oct 1;199(7):2503-2514. doi: 10.4049/jimmunol.1700687. Epub 2017 Aug 23.

PMID:
28835457
3.

How can we improve medical adherence to intranasal corticosteroids in children?

Ocak E, Kocaoz D, Acar B.

Int J Pediatr Otorhinolaryngol. 2017 Sep;100:194-197. doi: 10.1016/j.ijporl.2017.07.010. Epub 2017 Jul 12.

PMID:
28802371
4.

New Treatment Option for Chronic Obstructive Pulmonary Disease: Two Long-Acting Bronchodilators in a Single Metered-Dose Inhaler.

Self TH, Ellingson S.

Am J Med. 2017 Nov;130(11):1251-1254. doi: 10.1016/j.amjmed.2017.07.011. Epub 2017 Jul 27. Review. Erratum in: Am J Med. 2017 Dec 12;:.

PMID:
28757318
5.

Proposed algorithm for healthcare professionals based on product characteristics and in vitro performances in different use conditions using formoterol-based marketed products for inhalation.

Wauthoz N, Hennia I, Dejaeger B, Ecenarro S, Amighi K.

Int J Pharm. 2017 Sep 15;530(1-2):415-429. doi: 10.1016/j.ijpharm.2017.07.021. Epub 2017 Jul 27.

PMID:
28757256
6.

Baseline Symptom Score Impact on Benefits of Glycopyrrolate/Formoterol Metered Dose Inhaler in COPD.

Martinez FJ, Fabbri LM, Ferguson GT, Orevillo C, Darken P, Martin UJ, Reisner C.

Chest. 2017 Dec;152(6):1169-1178. doi: 10.1016/j.chest.2017.07.007. Epub 2017 Jul 16.

7.

[The role of topical glucocorticoids in the treatment of rhinosinusitis].

Shakhova EG.

Vestn Otorinolaringol. 2017;82(2):70-73. doi: 10.17116/otorino201782270-73. Russian.

PMID:
28514369
8.

GFF MDI for the improvement of lung function in COPD - A look at the PINNACLE-1 and PINNACLE-2 data and beyond.

Rabe KF.

Expert Rev Clin Pharmacol. 2017 Jul;10(7):685-698. doi: 10.1080/17512433.2017.1320218. Epub 2017 May 2.

PMID:
28443352
9.

Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary disease.

Hanania NA, Tashkin DP, Kerwin EM, Donohue JF, Denenberg M, O'Donnell DE, Quinn D, Siddiqui S, Orevillo C, Maes A, Reisner C.

Respir Med. 2017 May;126:105-115. doi: 10.1016/j.rmed.2017.03.015. Epub 2017 Mar 12.

10.

Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment.

Jenkins CR, Eriksson G, Bateman ED, Reddel HK, Sears MR, Lindberg M, O'Byrne PM.

BMC Pulm Med. 2017 Apr 20;17(1):65. doi: 10.1186/s12890-017-0401-y.

11.

Symptom variability and control in COPD: Advantages of dual bronchodilation therapy.

Di Marco F, Santus P, Scichilone N, Solidoro P, Contoli M, Braido F, Corsico AG.

Respir Med. 2017 Apr;125:49-56. doi: 10.1016/j.rmed.2017.03.001. Epub 2017 Mar 2. Review.

12.

A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium/formoterol or monotherapy in the treatment of chronic obstructive pulmonary disease.

D'Urzo A, Rennard S, Kerwin E, Donohue JF, Lei A, Molins E, Leselbaum A.

Respir Med. 2017 Apr;125:39-48. doi: 10.1016/j.rmed.2017.02.008. Epub 2017 Feb 16.

PMID:
28340861
13.

Impaired Dual-Specificity Protein Phosphatase DUSP4 Reduces Corticosteroid Sensitivity.

Kobayashi Y, Ito K, Kanda A, Tomoda K, Mercado N, Barnes PJ.

Mol Pharmacol. 2017 May;91(5):475-481. doi: 10.1124/mol.116.107656. Epub 2017 Mar 10.

PMID:
28283554
14.

Topical safety and vasoconstrictive assay-based bioequivalence of a new reformulated mometasone cream.

Krishna R, Horowitz A, Larson P, Bolognese J, Marcantonio EE.

Drug Dev Ind Pharm. 2017 Jul;43(7):1173-1177. doi: 10.1080/03639045.2017.1301949. Epub 2017 Mar 21.

PMID:
28277845
15.

Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations.

Scichilone N, Braido F, Lavorini F, Levy ML, Usmani OS.

Drugs Aging. 2017 May;34(5):321-330. doi: 10.1007/s40266-017-0449-7. Review.

PMID:
28258535
16.

Efficacy and safety of budesonide/formoterol pMDI vs budesonide pMDI in asthmatic children (6-<12 years).

Pearlman DS, Eckerwall G, McLaren J, Lamarca R, Puu M, Gilbert I, Jorup C, Sandin K, Lanz MJ.

Ann Allergy Asthma Immunol. 2017 Apr;118(4):489-499.e1. doi: 10.1016/j.anai.2017.01.020. Epub 2017 Mar 1.

17.

Real life dose emission characterization using COPD patient inhalation profiles when they inhaled using a fixed dose combination (FDC) of the medium strength Symbicort® Turbuhaler®.

Bagherisadeghi G, Larhrib EH, Chrystyn H.

Int J Pharm. 2017 Apr 30;522(1-2):137-146. doi: 10.1016/j.ijpharm.2017.02.057. Epub 2017 Feb 28.

PMID:
28254655
18.

Randomized Clinical Trial of a Combination of an Inhaled Corticosteroid and Beta Agonist in Patients at Risk of Developing the Acute Respiratory Distress Syndrome.

Festic E, Carr GE, Cartin-Ceba R, Hinds RF, Banner-Goodspeed V, Bansal V, Asuni AT, Talmor D, Rajagopalan G, Frank RD, Gajic O, Matthay MA, Levitt JE.

Crit Care Med. 2017 May;45(5):798-805. doi: 10.1097/CCM.0000000000002284.

PMID:
28240689
19.

Intranasal azelastine and mometasone exhibit a synergistic effect on a murine model of allergic rhinitis.

Kim DH, Kim BY, Shin JH, Kim SW, Kim SW.

Am J Otolaryngol. 2017 Mar - Apr;38(2):198-203. doi: 10.1016/j.amjoto.2017.01.008. Epub 2017 Jan 18.

PMID:
28117118
20.

Antibiofilm effects of topical corticosteroids and intranasal saline in patients with chronic rhinosinusitis with nasal polyps depend on bacterial species and their biofilm-forming capacity.

Cirkovic I, Pavlovic B, Bozic DD, Jotic A, Bakic L, Milovanovic J.

Eur Arch Otorhinolaryngol. 2017 Apr;274(4):1897-1903. doi: 10.1007/s00405-017-4454-6. Epub 2017 Jan 23.

PMID:
28116488

Supplemental Content

Loading ...
Support Center